General Information of Drug (ID: DMW8UQX)

Drug Name
RV001V
Indication
Disease Entry ICD 11 Status REF
Prostate cancer 2C82.0 Phase 2 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
DD76ER

References

1 ClinicalTrials.gov (NCT04114825) Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer (BRaVac). U.S. National Institutes of Health.